|
US4309430A
(en)
|
1980-06-27 |
1982-01-05 |
Merck & Co., Inc. |
Pyrazinyl-1,2,4-oxadiazole-5-ones, for treatment of edema, and processes for preparing same
|
|
US5329012A
(en)
|
1987-10-29 |
1994-07-12 |
The Research Foundation Of State University Of New York |
Bis(acyloxmethyl)imidazole compounds
|
|
JP2597917B2
(ja)
|
1990-04-26 |
1997-04-09 |
富士写真フイルム株式会社 |
新規な色素形成カプラー及びそれを用いたハロゲン化銀カラー写真感光材料
|
|
CN1183783A
(zh)
|
1995-05-09 |
1998-06-03 |
巴斯福股份公司 |
吡啶并[1,5α]嘧啶、其制备和应用
|
|
EP0914318A1
(en)
|
1996-05-11 |
1999-05-12 |
Kings College London |
Pyrazines
|
|
US6191131B1
(en)
|
1997-07-23 |
2001-02-20 |
Dupont Pharmaceuticals Company |
Azolo triazines and pyrimidines
|
|
US6060478A
(en)
|
1996-07-24 |
2000-05-09 |
Dupont Pharmaceuticals |
Azolo triazines and pyrimidines
|
|
JPH10218881A
(ja)
|
1997-02-03 |
1998-08-18 |
Pola Chem Ind Inc |
新規なピロロピラゾロピリミジン誘導体
|
|
GB2323861B
(en)
|
1997-02-05 |
2001-06-20 |
Sector Exhibiting Systems |
Artificial wall structure
|
|
JP2002241379A
(ja)
|
1997-03-21 |
2002-08-28 |
Dainippon Pharmaceut Co Ltd |
３−オキサジアゾリルキノキサリン誘導体
|
|
US6235741B1
(en)
|
1997-05-30 |
2001-05-22 |
Merck & Co., Inc. |
Angiogenesis inhibitors
|
|
CA2291709A1
(en)
|
1997-05-30 |
1998-12-03 |
Merck & Co., Inc. |
Novel angiogenesis inhibitors
|
|
AU748816B2
(en)
|
1998-07-16 |
2002-06-13 |
Shionogi & Co., Ltd. |
Pyrimidine derivatives exhibiting antitumor activity
|
|
US6245759B1
(en)
|
1999-03-11 |
2001-06-12 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
US6660753B2
(en)
|
1999-08-19 |
2003-12-09 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
JP2001302666A
(ja)
|
1999-09-21 |
2001-10-31 |
Nissan Chem Ind Ltd |
アゾール縮合ヘテロ環アニライド化合物及び除草剤
|
|
MY125533A
(en)
|
1999-12-06 |
2006-08-30 |
Bristol Myers Squibb Co |
Heterocyclic dihydropyrimidine compounds
|
|
DE60037905T2
(de)
|
1999-12-17 |
2009-01-29 |
Novartis Vaccines and Diagnostics, Inc., Emeryville |
Pyrazin-basierte hemmer der glycogen-synthase-kinase 3
|
|
AU2001264932A1
(en)
|
2000-05-26 |
2001-12-11 |
Neurogen Corporation |
Oxo-imidazopyrimidine-carboxamides and their use as gaba brain receptor ligands
|
|
US20020041880A1
(en)
|
2000-07-05 |
2002-04-11 |
Defeo-Jones Deborah |
Method of treating cancer
|
|
US6849660B1
(en)
|
2000-08-01 |
2005-02-01 |
Isis Pharmaceuticals, Inc. |
Antimicrobial biaryl compounds
|
|
US7067520B2
(en)
|
2000-11-17 |
2006-06-27 |
Ishihara Sangyo Kaisha, Ltd. |
Preventive or therapeutic medicines for diabetes containing fused-heterocyclic compounds or their salts
|
|
EP1217000A1
(en)
|
2000-12-23 |
2002-06-26 |
Aventis Pharma Deutschland GmbH |
Inhibitors of factor Xa and factor VIIa
|
|
GB0103926D0
(en)
|
2001-02-17 |
2001-04-04 |
Astrazeneca Ab |
Chemical compounds
|
|
DE60229059D1
(de)
|
2001-05-08 |
2008-11-06 |
Univ Yale |
Proteomimetische verbindungen und verfahren
|
|
US20030114467A1
(en)
|
2001-06-21 |
2003-06-19 |
Shakespeare William C. |
Novel pyrazolo- and pyrrolo-pyrimidines and uses thereof
|
|
SE0102438D0
(sv)
|
2001-07-05 |
2001-07-05 |
Astrazeneca Ab |
New compounds
|
|
SE0102439D0
(sv)
|
2001-07-05 |
2001-07-05 |
Astrazeneca Ab |
New compounds
|
|
WO2003037900A2
(en)
|
2001-11-01 |
2003-05-08 |
Icagen, Inc. |
Pyrazolopyrimidines
|
|
US6992087B2
(en)
|
2001-11-21 |
2006-01-31 |
Pfizer Inc |
Substituted aryl 1,4-pyrazine derivatives
|
|
MXPA04004714A
(es)
|
2001-11-21 |
2004-08-19 |
Upjohn Co |
Derivados de aril 1,4-pirazina sustituidos.
|
|
SG159380A1
(en)
|
2002-02-06 |
2010-03-30 |
Vertex Pharma |
Heteroaryl compounds useful as inhibitors of gsk-3
|
|
AU2003218738B2
(en)
|
2002-03-13 |
2009-01-08 |
Janssen Pharmaceutica N.V. |
Sulfonyl-derivatives as novel inhibitors of histone deacetylase
|
|
GB0206860D0
(en)
|
2002-03-22 |
2002-05-01 |
Glaxo Group Ltd |
Compounds
|
|
TWI319387B
(en)
|
2002-04-05 |
2010-01-11 |
Astrazeneca Ab |
Benzamide derivatives
|
|
AU2003227437A1
(en)
*
|
2002-04-23 |
2003-11-10 |
Shionogi And Co., Ltd. |
PYRAZOLO(1,5-a)PYRIMIDINE DERIVATIVE AND NAD(P)H OXIDASE INHIBITOR CONTAINING THE SAME
|
|
GB0209715D0
(en)
|
2002-04-27 |
2002-06-05 |
Astrazeneca Ab |
Chemical compounds
|
|
CA2484209C
(en)
|
2002-05-03 |
2013-06-11 |
Exelixis, Inc. |
Protein kinase modulators and methods of use
|
|
US7704995B2
(en)
|
2002-05-03 |
2010-04-27 |
Exelixis, Inc. |
Protein kinase modulators and methods of use
|
|
TW200406385A
(en)
|
2002-05-31 |
2004-05-01 |
Eisai Co Ltd |
Pyrazole compound and pharmaceutical composition containing the same
|
|
DE60319820T2
(de)
|
2002-06-04 |
2009-03-26 |
Schering Corp. |
Pyrazoloä1,5-aüpyrimidin-verbindungen als antivirale agentien
|
|
US7449488B2
(en)
|
2002-06-04 |
2008-11-11 |
Schering Corporation |
Pyrazolopyrimidines as protein kinase inhibitors
|
|
AU2003249369A1
(en)
|
2002-06-21 |
2004-01-06 |
Cellular Genomics, Inc. |
Certain amino-substituted monocycles as kinase modulators
|
|
US8673924B2
(en)
|
2002-09-04 |
2014-03-18 |
Merck Sharp & Dohme Corp. |
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
|
|
US7196078B2
(en)
|
2002-09-04 |
2007-03-27 |
Schering Corpoartion |
Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
|
EP1537116B1
(en)
|
2002-09-04 |
2010-06-02 |
Schering Corporation |
Pyrazolopyrimidines suitable for the treatment of cancer diseases
|
|
NZ539162A
(en)
|
2002-09-04 |
2006-07-28 |
Schering Corp |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
|
US7119200B2
(en)
|
2002-09-04 |
2006-10-10 |
Schering Corporation |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
|
US7563798B2
(en)
|
2002-09-04 |
2009-07-21 |
Schering Corporation |
Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
|
|
US8580782B2
(en)
|
2002-09-04 |
2013-11-12 |
Merck Sharp & Dohme Corp. |
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
|
|
DE60313872T2
(de)
|
2002-09-04 |
2008-01-17 |
Schering Corp. |
Pyrazoloä1,5-aüpyrimidine als hemmstoffe cyclin-abhängiger kinasen
|
|
US7601724B2
(en)
|
2002-09-04 |
2009-10-13 |
Schering Corporation |
Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
|
|
AU2003268385B2
(en)
|
2002-09-04 |
2006-12-21 |
Pharmacopeia, Inc. |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
|
US7196092B2
(en)
|
2002-09-04 |
2007-03-27 |
Schering Corporation |
N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
|
|
US7205308B2
(en)
|
2002-09-04 |
2007-04-17 |
Schering Corporation |
Trisubstituted 7-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors
|
|
AU2003282679A1
(en)
|
2002-10-04 |
2004-05-04 |
Arena Pharmaceuticals, Inc. |
Hydroxypyrazoles for use against metabolic-related disorders
|
|
US7138402B2
(en)
|
2003-09-18 |
2006-11-21 |
Conforma Therapeutics Corporation |
Pyrrolopyrimidines and related analogs as HSP90-inhibitors
|
|
WO2004052315A2
(en)
|
2002-12-11 |
2004-06-24 |
Merck & Co., Inc. |
Tyrosine kinase inhibitors
|
|
SE0203752D0
(sv)
|
2002-12-17 |
2002-12-17 |
Astrazeneca Ab |
New compounds
|
|
SE0203754D0
(sv)
|
2002-12-17 |
2002-12-17 |
Astrazeneca Ab |
New compounds
|
|
US7230098B2
(en)
|
2003-02-26 |
2007-06-12 |
Sugen, Inc. |
Aminoheteroaryl compounds as protein kinase inhibitors
|
|
MXPA05008955A
(es)
|
2003-02-28 |
2006-02-22 |
Teijin Pharma Ltd |
Derivados de pirazolo [1,5-a] pirimidina.
|
|
MXPA05009245A
(es)
|
2003-03-11 |
2005-10-19 |
Pfizer Prod Inc |
Nuevos compuestos de pirazina como inhibidores del factor de crecimiento transformante (tgf).
|
|
JP2006520794A
(ja)
|
2003-03-21 |
2006-09-14 |
スミスクライン ビーチャム コーポレーション |
化合物
|
|
CN101468965A
(zh)
|
2003-03-24 |
2009-07-01 |
默克公司 |
联芳基取代的6元杂环钠通道阻滞剂
|
|
GB2400101A
(en)
|
2003-03-28 |
2004-10-06 |
Biofocus Discovery Ltd |
Compounds capable of binding to the active site of protein kinases
|
|
US20060252741A1
(en)
|
2003-05-15 |
2006-11-09 |
Colandrea Vincent J |
3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists
|
|
AR045595A1
(es)
|
2003-09-04 |
2005-11-02 |
Vertex Pharma |
Composiciones utiles como inhibidores de proteinas quinasas
|
|
WO2005034952A2
(en)
|
2003-10-07 |
2005-04-21 |
The Feinstein Institute For Medical Research |
Isoxazole and isothiazole compounds useful in the treatment of inflammation
|
|
AU2004293436B2
(en)
|
2003-11-19 |
2010-12-09 |
Array Biopharma Inc. |
Heterocyclic inhibitors of MEK and methods of use thereof
|
|
DE10356579A1
(de)
*
|
2003-12-04 |
2005-07-07 |
Merck Patent Gmbh |
Aminderivate
|
|
CN1933838A
(zh)
|
2004-02-12 |
2007-03-21 |
默克公司 |
作为代谢型谷氨酸受体－5调节剂的联吡啶酰胺
|
|
US20070197389A1
(en)
|
2004-02-25 |
2007-08-23 |
Anja Schwogler |
Azolopyrimidine compounds and use thereof for combating parasitic fungi
|
|
JP5213229B2
(ja)
|
2004-04-23 |
2013-06-19 |
エグゼリクシス， インコーポレイテッド |
キナーゼ調節因子および使用方法
|
|
WO2005123672A2
(en)
|
2004-06-14 |
2005-12-29 |
Takeda San Diego, Inc. |
Kinase inhibitors
|
|
US7626021B2
(en)
|
2004-07-27 |
2009-12-01 |
Sgx Pharmaceuticals, Inc. |
Fused ring heterocycle kinase modulators
|
|
AU2005269387A1
(en)
|
2004-07-27 |
2006-02-09 |
Sgx Pharmaceuticals, Inc. |
Fused ring heterocycle kinase modulators
|
|
KR20070090172A
(ko)
|
2004-11-04 |
2007-09-05 |
버텍스 파마슈티칼스 인코포레이티드 |
단백질 키나아제의 억제제로서 유용한피라졸로[1,5-ａ]피리미딘
|
|
EP1828144A2
(en)
|
2004-11-12 |
2007-09-05 |
OSI Pharmaceuticals, Inc. |
Integrin antagonists useful as anticancer agents
|
|
EP1814882A1
(en)
|
2004-11-22 |
2007-08-08 |
Vertex Pharmaceuticals Incorporated |
Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases
|
|
GB0428235D0
(en)
|
2004-12-23 |
2005-01-26 |
Glaxo Group Ltd |
Novel compounds
|
|
CA2590261C
(en)
|
2004-12-27 |
2011-08-16 |
Alcon, Inc. |
Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases and conditions
|
|
US7635699B2
(en)
|
2004-12-29 |
2009-12-22 |
Bristol-Myers Squibb Company |
Azolopyrimidine-based inhibitors of dipeptidyl peptidase IV and methods
|
|
GB0500492D0
(en)
|
2005-01-11 |
2005-02-16 |
Cyclacel Ltd |
Compound
|
|
US7622583B2
(en)
|
2005-01-14 |
2009-11-24 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2
|
|
US20060156482A1
(en)
|
2005-01-14 |
2006-07-20 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
|
GB0501999D0
(en)
|
2005-02-01 |
2005-03-09 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
|
MX2007009945A
(es)
|
2005-02-16 |
2007-09-26 |
Schering Corp |
Piperazinas sustituidas con heterociclicos con actividad antagonista de cxcr3.
|
|
DE102005007534A1
(de)
|
2005-02-17 |
2006-08-31 |
Bayer Cropscience Ag |
Pyrazolopyrimidine
|
|
EP1874769B1
(de)
|
2005-04-25 |
2011-09-14 |
Merck Patent GmbH |
Neuartige aza-heterozyklen als kinase-inhibitoren
|
|
AU2006251989B2
(en)
|
2005-05-20 |
2010-05-27 |
Alantos-Pharmaceuticals, Inc. |
Pyrimidine or triazine fused bicyclic metalloprotease inhibitors
|
|
US20070155737A1
(en)
|
2005-05-20 |
2007-07-05 |
Alantos Pharmaceuticals, Inc. |
Heterobicyclic metalloprotease inhibitors
|
|
US20070155738A1
(en)
|
2005-05-20 |
2007-07-05 |
Alantos Pharmaceuticals, Inc. |
Heterobicyclic metalloprotease inhibitors
|
|
WO2007015632A1
(en)
|
2005-08-04 |
2007-02-08 |
Cgk Co., Ltd. |
Atm and atr inhibitor
|
|
TW200745128A
(en)
|
2005-10-06 |
2007-12-16 |
Schering Corp |
Pyrazolopyrimidines as protein kinase inhibitors
|
|
TWI421078B
(zh)
|
2005-10-06 |
2014-01-01 |
Merck Sharp & Dohme |
關卡激酶抑制劑及其用途
|
|
US7776865B2
(en)
|
2005-10-06 |
2010-08-17 |
Schering Corporation |
Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
|
|
WO2007044426A2
(en)
|
2005-10-06 |
2007-04-19 |
Schering Corporation |
Pyrazolopyrimidines as protein kinase inhibitors
|
|
EP1945220A1
(en)
|
2005-10-21 |
2008-07-23 |
Mitsubishi Tanabe Pharma Corporation |
Pyrazolo[1,5-a]pyrimidine compounds as cannabinoid receptor antagonists
|
|
JP5376950B2
(ja)
|
2005-10-21 |
2013-12-25 |
エクセリクシス， インク． |
カゼインキナーゼｉｉ（ｃｋ２）モジュレーターとしてのピリミジオン類
|
|
TW200736260A
(en)
|
2005-11-10 |
2007-10-01 |
Smithkline Beecham Corp |
Inhibitors of Akt activity
|
|
DE602006011363D1
(de)
|
2005-12-01 |
2010-02-04 |
Hoffmann La Roche |
Heteroaryl-substituierte piperidin-derivate als l-cpt1-hemmer
|
|
EP1970377A4
(en)
|
2005-12-09 |
2013-02-27 |
Meiji Seika Kaisha |
LINCOMYCIN DERIVATIVE AND ANTIBACTERIAL AGENT CONTAINING THIS AS AN ACTIVE SUBSTANCE
|
|
CN101340912A
(zh)
|
2005-12-22 |
2009-01-07 |
爱尔康研究有限公司 |
用于治疗rho激酶介导的疾病和病状的(吲唑-5-基)-吡嗪和(1,3-二氢-吲哚-2-酮)-吡嗪
|
|
ITMI20060311A1
(it)
|
2006-02-21 |
2007-08-22 |
Btsr Int Spa |
Dispositivo perfezionato di alimentazione di filo o filatio ad una macchina tessile e metodo per attuare tale alimentazione
|
|
GB0603684D0
(en)
|
2006-02-23 |
2006-04-05 |
Novartis Ag |
Organic compounds
|
|
WO2007096764A2
(en)
|
2006-02-27 |
2007-08-30 |
Glenmark Pharmaceuticals S.A. |
Bicyclic heteroaryl derivatives as cannabinoid receptor modulators
|
|
TW200800203A
(en)
|
2006-03-08 |
2008-01-01 |
Astrazeneca Ab |
New use
|
|
JP2009533327A
(ja)
|
2006-03-22 |
2009-09-17 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
増殖性疾患を処置するためのｃ−ＭＥＴキナーゼ阻害剤
|
|
EP2007373A4
(en)
|
2006-03-29 |
2012-12-19 |
Foldrx Pharmaceuticals Inc |
INHIBITION OF ALPHA SYNUCLEINE TOXICITY
|
|
WO2007126964A2
(en)
|
2006-03-31 |
2007-11-08 |
Schering Corporation |
Kinase inhibitors
|
|
CN101495481A
(zh)
|
2006-05-22 |
2009-07-29 |
先灵公司 |
作为CDK抑制剂的吡唑并[1,5-α]嘧啶
|
|
BRPI0713328A2
(pt)
|
2006-06-22 |
2012-10-30 |
Biovitrum Ab |
derivados de piridina e pirazina como inibidores de cinase mnk
|
|
EP2038261A2
(en)
|
2006-06-22 |
2009-03-25 |
Mallinckrodt Inc. |
Pyrazine derivatives with extended conjugation and uses thereof
|
|
AR061793A1
(es)
|
2006-07-05 |
2008-09-24 |
Mitsubishi Tanabe Pharma Corp |
Compuesto de pirazolo[1,5-a] pirimidina y composicion farmaceutica
|
|
US8217177B2
(en)
|
2006-07-14 |
2012-07-10 |
Amgen Inc. |
Fused heterocyclic derivatives and methods of use
|
|
US8198448B2
(en)
|
2006-07-14 |
2012-06-12 |
Amgen Inc. |
Fused heterocyclic derivatives and methods of use
|
|
PE20121506A1
(es)
|
2006-07-14 |
2012-11-26 |
Amgen Inc |
Compuestos triazolopiridinas como inhibidores de c-met
|
|
KR20090073121A
(ko)
|
2006-09-29 |
2009-07-02 |
노파르티스 아게 |
Ｐｉ3ｋ 지질 키나제 억제제로서의 피라졸로피리미딘
|
|
GB0619342D0
(en)
|
2006-09-30 |
2006-11-08 |
Vernalis R&D Ltd |
New chemical compounds
|
|
MX2009003222A
(es)
|
2006-10-04 |
2009-04-06 |
Hoffmann La Roche |
Derivados de 3-piridinocarboxamida y 2-pirazinocarboxamida como agentes elevadores de colesterol de lipoproteina de alta densidad.
|
|
CN105693730A
(zh)
|
2006-10-19 |
2016-06-22 |
西格诺药品有限公司 |
杂芳基化合物、其组合物以及它们作为蛋白激酶抑制剂的用途
|
|
CN101600714B
(zh)
|
2006-11-10 |
2013-08-21 |
百时美施贵宝公司 |
吡咯并吡啶激酶抑制剂
|
|
EP2102211A2
(en)
|
2006-11-20 |
2009-09-23 |
Alantos Pharmaceuticals Holding, Inc. |
Heterobicyclic metalloprotease inhibitors
|
|
JP2010513232A
(ja)
|
2006-12-15 |
2010-04-30 |
バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト |
３−ｈ−ピラゾロピリジン類及びそれらの塩類、それらを含んで成る医薬組成物類、それらの調製方法及びそれらの使用
|
|
EP2125781A2
(en)
|
2006-12-20 |
2009-12-02 |
Amgen Inc. |
Substituted heterocycles and methods of use
|
|
GB0625659D0
(en)
|
2006-12-21 |
2007-01-31 |
Cancer Rec Tech Ltd |
Therapeutic compounds and their use
|
|
PE20081581A1
(es)
|
2006-12-21 |
2008-11-12 |
Plexxikon Inc |
COMPUESTOS PIRROLO[2,3-b]PIRIDINAS COMO MODULADORES DE QUINASA
|
|
MX2009008531A
(es)
|
2007-02-16 |
2009-08-26 |
Amgen Inc |
Cetonas de heterociclilo que contienen nitrogeno y su uso como inhibidores de c-met.
|
|
CN101679266B
(zh)
|
2007-03-01 |
2015-05-06 |
诺华股份有限公司 |
Pim激酶抑制剂及其应用方法
|
|
MX2009010071A
(es)
|
2007-04-10 |
2009-10-16 |
Bayer Cropscience Ag |
Derivados de aril isoxazolina insecticidas.
|
|
EP2150255A4
(en)
|
2007-05-10 |
2011-10-05 |
Glaxosmithkline Llc |
CHINOXALINE DERIVATIVES AS P13 KINASE INHIBITORS
|
|
PE20090717A1
(es)
|
2007-05-18 |
2009-07-18 |
Smithkline Beecham Corp |
Derivados de quinolina como inhibidores de la pi3 quinasa
|
|
EP2014661A1
(de)
|
2007-06-13 |
2009-01-14 |
Bayer CropScience AG |
Heterocyclisch substituierte Heterocyclyl-carbonsäurederivate
|
|
UY31137A1
(es)
|
2007-06-14 |
2009-01-05 |
Smithkline Beecham Corp |
Derivados de quinazolina como inhibidores de la pi3 quinasa
|
|
EP2157090A4
(en)
|
2007-06-21 |
2011-09-07 |
Taisho Pharmaceutical Co Ltd |
PYRAZINAMIDE COMPOUND
|
|
KR20100037047A
(ko)
|
2007-06-26 |
2010-04-08 |
렉시컨 파마슈티컬스 인코퍼레이티드 |
세로토닌-매개 질환 및 장애의 치료 방법
|
|
WO2009006580A1
(en)
|
2007-07-05 |
2009-01-08 |
Cv Therapeutics, Inc. |
Optionally condensed dihydropyridine, dihydropyrimidine and dihydropyrane derivatives acting as late sodium channel blockers
|
|
US20090012103A1
(en)
|
2007-07-05 |
2009-01-08 |
Matthew Abelman |
Substituted heterocyclic compounds
|
|
GB0713259D0
(en)
|
2007-07-09 |
2007-08-15 |
Astrazeneca Ab |
Pyrazine derivatives 954
|
|
CA2693967A1
(en)
|
2007-07-19 |
2009-01-29 |
Schering Corporation |
Heterocyclic amide compounds as protein kinase inhibitors
|
|
ES2551095T3
(es)
|
2007-07-19 |
2015-11-16 |
Lundbeck, H., A/S |
Amidas heterocíclicas de 5 miembros y compuestos relacionados
|
|
JP4792126B2
(ja)
|
2007-08-01 |
2011-10-12 |
ファイザー・インク |
ピラゾール化合物およびＲａｆ阻害剤としてのその使用
|
|
WO2009017954A1
(en)
|
2007-08-01 |
2009-02-05 |
Phenomix Corporation |
Inhibitors of jak2 kinase
|
|
WO2009024825A1
(en)
|
2007-08-21 |
2009-02-26 |
Astrazeneca Ab |
2-pyrazinylbenzimidazole derivatives as receptor tyrosine kinase inhibitors
|
|
WO2009037247A1
(en)
|
2007-09-17 |
2009-03-26 |
Neurosearch A/S |
Pyrazine derivatives and their use as potassium channel modulators
|
|
MX2010004491A
(es)
|
2007-10-25 |
2010-06-21 |
Astrazeneca Ab |
Derivados de piridina y pirazina utiles en el tratamiento de trastornos proliferativos celulares.
|
|
CA2706946A1
(en)
|
2007-11-28 |
2009-06-04 |
Schering Corporation |
2-fluoropyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
|
|
WO2009075790A1
(en)
|
2007-12-07 |
2009-06-18 |
Alantos Pharmaceuticals Holding, Inc. |
Metalloprotease inhibitors for intra-articular application
|
|
DK2240451T3
(da)
|
2008-01-04 |
2017-11-20 |
Intellikine Llc |
Isoquinolinonderivater substitueret med en purin, der er anvendelig som pi3k-inhibitorer
|
|
EP2085398A1
(en)
|
2008-02-01 |
2009-08-05 |
Merz Pharma GmbH & Co. KGaA |
Pyrazolopyrimidines, a process for their preparation and their use as medicine
|
|
PL2247592T3
(pl)
|
2008-02-25 |
2012-01-31 |
Hoffmann La Roche |
Pirolopirazynowe inhibitory kinazy
|
|
EP2247595B1
(en)
|
2008-02-25 |
2011-07-20 |
F. Hoffmann-La Roche AG |
Pyrrolopyrazine kinase inhibitors
|
|
CN101952294B
(zh)
|
2008-02-25 |
2014-11-26 |
霍夫曼-拉罗奇有限公司 |
吡咯并吡嗪激酶抑制剂
|
|
KR20100114095A
(ko)
|
2008-02-25 |
2010-10-22 |
에프. 호프만-라 로슈 아게 |
피롤로피라진 키나아제 저해제
|
|
TW200940537A
(en)
|
2008-02-26 |
2009-10-01 |
Astrazeneca Ab |
Heterocyclic urea derivatives and methods of use thereof
|
|
AU2009226024B2
(en)
|
2008-03-20 |
2012-07-12 |
Amgen Inc. |
Aurora kinase modulators and method of use
|
|
WO2009152087A1
(en)
|
2008-06-10 |
2009-12-17 |
Plexxikon, Inc. |
Bicyclic heteroaryl compounds and methods for kinase modulation, and indications therefor
|
|
BRPI0915231A2
(pt)
|
2008-07-08 |
2018-06-12 |
Intellikine Inc |
compostos inibidores de quinase e métodos de uso
|
|
US8455477B2
(en)
|
2008-08-05 |
2013-06-04 |
Merck Sharp & Dohme Corp. |
Therapeutic compounds
|
|
GB0814364D0
(en)
|
2008-08-05 |
2008-09-10 |
Eisai London Res Lab Ltd |
Diazaindole derivatives and their use in the inhibition of c-Jun N-terminal kinase
|
|
BRPI0919085B1
(pt)
|
2008-09-24 |
2021-05-11 |
Basf Se |
métodos não terapêuticos para controlar pragas invertebradas e para proteger material de propagação de plantas e/ou plantas que se desenvolvem dos mesmos, compostos de pirazol ou um sal ou um n-óxido dos mesmos, e, composição agrícola
|
|
JP2012506381A
(ja)
|
2008-10-21 |
2012-03-15 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
ｃ−ＭＥＴタンパク質キナーゼ阻害剤
|
|
EP2348860B1
(en)
|
2008-10-31 |
2015-05-27 |
Genentech, Inc. |
Pyrazolopyrimidine jak inhibitor compounds and methods
|
|
KR20170015566A
(ko)
|
2008-11-10 |
2017-02-08 |
버텍스 파마슈티칼스 인코포레이티드 |
Ａｔｒ 키나제의 억제제로서 유용한 화합물
|
|
WO2010059836A1
(en)
|
2008-11-20 |
2010-05-27 |
Decode Genetics Ehf |
Substituted aza-bridged bicyclics for cardiovascular and cns disease
|
|
JP5930278B2
(ja)
|
2008-11-25 |
2016-06-08 |
ユニバーシティー オブ ロチェスター |
Ｍｌｋ阻害剤および使用方法
|
|
CN102232076B
(zh)
|
2008-12-05 |
2014-12-31 |
霍夫曼-拉罗奇有限公司 |
吡咯并吡嗪基脲激酶抑制剂
|
|
EP2376485B1
(en)
|
2008-12-19 |
2017-12-06 |
Vertex Pharmaceuticals Incorporated |
Pyrazine derivatives useful as inhibitors of atr kinase
|
|
MX2011006332A
(es)
|
2008-12-23 |
2011-06-27 |
Abbott Lab |
Compuestos antivirales.
|
|
WO2010086040A1
(en)
|
2009-01-29 |
2010-08-05 |
Biomarin Iga, Ltd. |
Pyrazolo-pyrimidines for treatment of duchenne muscular dystrophy
|
|
JP5602641B2
(ja)
|
2009-01-30 |
2014-10-08 |
富山化学工業株式会社 |
Ｎ−アシルアントラニル酸誘導体またはその塩
|
|
US20100204265A1
(en)
|
2009-02-09 |
2010-08-12 |
Genelabs Technologies, Inc. |
Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections
|
|
WO2010093425A1
(en)
|
2009-02-11 |
2010-08-19 |
Sepracor Inc. |
Histamine h3 inverse agonists and antagonists and methods of use thereof
|
|
CN101537007A
(zh)
|
2009-03-18 |
2009-09-23 |
中国医学科学院血液病医院（血液学研究所） |
N-(噻吩-2)吡唑并[1,5-a]嘧啶-3-甲酰胺类化合物在制备抗恶性肿瘤药物方面的应用
|
|
EP2411007A4
(en)
|
2009-03-27 |
2012-12-05 |
Uab Research Foundation |
MODULATION OF IRES-MEDIATED TRANSLATION
|
|
UA110324C2
(en)
|
2009-07-02 |
2015-12-25 |
Genentech Inc |
Jak inhibitory compounds based on pyrazolo pyrimidine
|
|
JP2012533551A
(ja)
|
2009-07-15 |
2012-12-27 |
アボット・ラボラトリーズ |
ピロロピラジン系キナーゼ阻害薬
|
|
CN102573846B
(zh)
|
2009-08-17 |
2015-10-07 |
因特利凯公司 |
杂环化合物及其用途
|
|
WO2011025706A2
(en)
|
2009-08-26 |
2011-03-03 |
Schering Corporation |
Heterocyclic amide compounds as protein kinase inhibitors
|
|
CN101671336B
(zh)
|
2009-09-23 |
2013-11-13 |
辽宁利锋科技开发有限公司 |
芳杂环并嘧啶衍生物和类似物及其制备方法和用途
|
|
US8575177B2
(en)
|
2009-12-04 |
2013-11-05 |
Senhwa Biosciences, Inc. |
Pyrazolopyrimidines and related heterocycles as CK2 inhibitors
|
|
AU2011229423B2
(en)
|
2010-03-18 |
2015-12-10 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Anti-infective compounds
|
|
US8518945B2
(en)
|
2010-03-22 |
2013-08-27 |
Hoffmann-La Roche Inc. |
Pyrrolopyrazine kinase inhibitors
|
|
WO2011121096A1
(en)
|
2010-03-31 |
2011-10-06 |
Dkfz Deutsches Krebsforschungszentrum |
PYRAZOL[1,5-a]PYRIMIDINE DERIVATIVES AS WNT PATHWAY ANTAGONISTS
|
|
CN102933563A
(zh)
|
2010-04-08 |
2013-02-13 |
Ah美国42有限责任公司 |
作为杀虫剂和杀螨剂的取代的3,5-二苯基异噁唑啉衍生物
|
|
US20130030237A1
(en)
|
2010-04-15 |
2013-01-31 |
Charles Theuer |
Potentiation of anti-cancer activity through combination therapy with ber pathway inhibitors
|
|
JP2013526540A
(ja)
|
2010-05-12 |
2013-06-24 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ａｔｒキナーゼ阻害剤として有用な化合物
|
|
US8962631B2
(en)
|
2010-05-12 |
2015-02-24 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
|
EP2569286B1
(en)
|
2010-05-12 |
2014-08-20 |
Vertex Pharmaceuticals Inc. |
Compounds useful as inhibitors of atr kinase
|
|
AU2011253021A1
(en)
|
2010-05-12 |
2012-11-29 |
Vertex Pharmaceuticals Incorporated |
2 -aminopyridine derivatives useful as inhibitors of ATR kinase
|
|
KR20130066633A
(ko)
|
2010-05-12 |
2013-06-20 |
버텍스 파마슈티칼스 인코포레이티드 |
Ａｔｒ 키나제의 억제제로서 유용한 화합물
|
|
EP2568984A1
(en)
|
2010-05-12 |
2013-03-20 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
|
JP2013529204A
(ja)
|
2010-05-20 |
2013-07-18 |
エフ．ホフマン−ラ ロシュ アーゲー |
ピロロ［２，３−ｂ］ピラジン−７−カルボキサミド誘導体とＪＡＫ及びＳＹＫ及び阻害剤としてのそれらの使用
|
|
CA2798970A1
(en)
|
2010-05-20 |
2011-11-24 |
F. Hoffmann-La Roche Ag |
Pyrrolopyrazine derivatives as syk and jak inhibitors
|
|
MX2013000103A
(es)
|
2010-06-23 |
2013-06-13 |
Vertex Pharma |
Derivados de pirrolo-pirazina utiles como inhibidores de cinasa art.
|
|
HUE029174T2
(hu)
|
2010-06-24 |
2017-02-28 |
Gilead Sciences Inc |
Pirazolo[1,5-A]pirimidinek és -triazinok mint antivirális szerek
|
|
CN102311396B
(zh)
|
2010-07-05 |
2015-01-07 |
暨南大学 |
一种吡嗪类衍生物和其制备方法及在制药中的应用
|
|
MX358682B
(es)
|
2010-07-13 |
2018-08-31 |
Hoffmann La Roche |
Derivados de pirazolo [1,5a]pirimidina y de tieno[3,2b] pirimidina como moduladores de la cinasa asociada al receptor de la interleucina 4 (irak4).
|
|
EP2407478A1
(en)
|
2010-07-14 |
2012-01-18 |
GENETADI Biotech, S.L. |
New cyclotetrapeptides with pro-angiogenic properties
|
|
WO2012022045A1
(en)
|
2010-08-20 |
2012-02-23 |
Hutchison Medipharma Limited |
Pyrrolopyrimidine compounds and uses thereof
|
|
US8883801B2
(en)
|
2010-08-23 |
2014-11-11 |
Merck Sharp & Dohme Corp. |
Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors
|
|
EP2621925B1
(en)
*
|
2010-09-28 |
2017-06-21 |
Merck Sharp & Dohme Corp. |
Fused tricyclic inhibitors of mammalian target of rapamycin
|
|
RU2017127088A
(ru)
|
2010-11-16 |
2019-02-04 |
Эррэй Биофарма Инк. |
Комбинация ингибиторов чекпойнт-киназы 1 и ингибиторов киназы wee 1
|
|
US8609669B2
(en)
|
2010-11-16 |
2013-12-17 |
Abbvie Inc. |
Potassium channel modulators
|
|
RS63320B1
(sr)
|
2010-12-08 |
2022-07-29 |
The U S A As Represented By The Secretary Department Of Health And Human Services |
Supstituisani pirazolopirimidini kao aktivatori glukocerebrozidaze
|
|
WO2012100342A1
(en)
|
2011-01-27 |
2012-08-02 |
Université de Montréal |
Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators
|
|
JP2014510151A
(ja)
|
2011-04-05 |
2014-04-24 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ａｔｒキナーゼ（ｔｒａｋｉｎａｓｅ）阻害剤として有用なアミノピラジン化合物
|
|
KR20140093610A
(ko)
|
2011-04-21 |
2014-07-28 |
재단법인 한국파스퇴르연구소 |
소염 화합물
|
|
US9090610B2
(en)
|
2011-04-21 |
2015-07-28 |
Bayer Intellectual Property Gmbh |
Fluoroalkyl-substituted pyrazolopyridines and use thereof
|
|
MX2013013331A
(es)
|
2011-05-17 |
2014-10-17 |
Principia Biopharma Inc |
Derivados de azaindol como inhibidores de tirosina-cinasas.
|
|
WO2012178123A1
(en)
|
2011-06-22 |
2012-12-27 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
|
JP2014522818A
(ja)
|
2011-06-22 |
2014-09-08 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ａｔｒキナーゼ阻害剤として有用な化合物
|
|
US9845327B2
(en)
|
2011-06-22 |
2017-12-19 |
The General Hospital Corporation |
Treatment of proteinopathies
|
|
EP2723746A1
(en)
|
2011-06-22 |
2014-04-30 |
Vertex Pharmaceuticals Inc. |
Compounds useful as inhibitors of atr kinase
|
|
AU2012283775A1
(en)
|
2011-07-13 |
2014-01-23 |
Pharmacyclics Llc |
Inhibitors of Bruton's tyrosine kinase
|
|
WO2013052263A2
(en)
|
2011-09-16 |
2013-04-11 |
Microbiotix, Inc. |
Antifungal compounds
|
|
EP2751099B1
(en)
|
2011-09-30 |
2017-06-14 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
|
WO2013049720A1
(en)
|
2011-09-30 |
2013-04-04 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
|
KR102056586B1
(ko)
|
2011-09-30 |
2019-12-18 |
버텍스 파마슈티칼스 인코포레이티드 |
Ａｔｒ 억제제를 이용한 췌장암 및 비소세포 폐암의 치료
|
|
WO2013049719A1
(en)
|
2011-09-30 |
2013-04-04 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
|
BR112014007721B1
(pt)
|
2011-09-30 |
2022-11-01 |
Vertex Pharmaceuticals Incorporated |
Processos para preparar compostos úteis como inibidores de atr quinase
|
|
CN104394869A
(zh)
|
2011-10-20 |
2015-03-04 |
葛兰素史密斯克莱有限责任公司 |
用作沉默调节蛋白调节剂的取代的双环氮杂杂环化合物和类似物
|
|
US8841449B2
(en)
|
2011-11-09 |
2014-09-23 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of ATR kinase
|
|
WO2013071090A1
(en)
|
2011-11-09 |
2013-05-16 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
|
EP2776421A1
(en)
|
2011-11-09 |
2014-09-17 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
|
WO2013071093A1
(en)
|
2011-11-09 |
2013-05-16 |
Vertex Pharmaceuticals Incorporated |
Pyrazine compounds useful as inhibitors of atr kinase
|
|
WO2013071094A1
(en)
|
2011-11-09 |
2013-05-16 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
|
WO2013138436A1
(en)
|
2012-03-14 |
2013-09-19 |
Bristol-Myers Squibb Company |
Cyclolic hydrazine derivatives as hiv attachment inhibitors
|
|
AR090548A1
(es)
|
2012-04-02 |
2014-11-19 |
Incyte Corp |
Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
|
|
US20150065525A1
(en)
|
2012-04-02 |
2015-03-05 |
Cytokinetics, Inc. |
Methods for improving diaphragm function
|
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
CN103373996A
(zh)
|
2012-04-20 |
2013-10-30 |
山东亨利医药科技有限责任公司 |
作为crth2受体拮抗剂的二并环衍生物
|
|
PL2855448T3
(pl)
|
2012-05-15 |
2017-09-29 |
Cancer Research Technology Ltd |
5-[[4-[[morfolino-2-ilo]metyloamino]-5-(trifluorometylo)-2-pirydylo]amino]pirazyno-2-karbonitryl i jego zastosowanie terapeutyczne
|
|
CN104334563B
(zh)
|
2012-05-23 |
2017-03-08 |
萨维拉制药有限公司 |
7‑氧代‑噻唑并吡啶碳酸衍生物和它们在治疗、改善或预防病毒疾病中的用途
|
|
US20130317021A1
(en)
|
2012-05-23 |
2013-11-28 |
Savira Pharmaceuticals Gmbh |
Heterocyclic pyrimidine carbonic acid derivatives which are useful in the treatment, amelioration or prevention of a viral disease
|
|
WO2014011911A2
(en)
|
2012-07-11 |
2014-01-16 |
Nimbus Iris, Inc. |
Irak inhibitors and uses thereof
|
|
WO2014015523A1
(en)
|
2012-07-27 |
2014-01-30 |
Hutchison Medipharma Limited |
Novel heteroaryl and heterocycle compounds, compositions and methods
|
|
BR112015002516A2
(pt)
|
2012-08-06 |
2017-07-04 |
European Molecular Biology Laboratory |
derivados de ácido carbônico di-hidroxipirimidina e seu uso no tratamento, melhora ou prevenção de doença viral.
|
|
ES2614034T3
(es)
|
2012-08-09 |
2017-05-29 |
VIIV Healthcare UK (No.5) Limited |
Derivados de amidina tricíclica como inhibidores de la unión del VIH
|
|
WO2014025852A1
(en)
|
2012-08-09 |
2014-02-13 |
Bristol-Myers Squibb Company |
Tricyclic alkene derivatives as hiv attachment inhibitors
|
|
WO2014025854A1
(en)
|
2012-08-09 |
2014-02-13 |
Bristol-Myers Squibb Company |
Piperidine amide derivatives as hiv attachment inhibitors
|
|
CN104718206B
(zh)
|
2012-08-17 |
2017-03-08 |
拜尔农作物科学股份公司 |
作为杀虫剂和杀螨剂的氮杂吲哚甲酰胺和氮杂吲哚硫代甲酰胺
|
|
KR20150046056A
(ko)
|
2012-08-24 |
2015-04-29 |
에프. 호프만-라 로슈 아게 |
신규한 바이사이클릭피리딘 유도체
|
|
WO2014035140A2
(en)
|
2012-08-30 |
2014-03-06 |
Kainos Medicine, Inc. |
Compounds and compositions for modulating histone methyltransferase activity
|
|
US9475816B2
(en)
|
2012-09-07 |
2016-10-25 |
Takeda Pharmaceutical Company Limited |
Substituted-1,4-dihydropyrazolo[4,3-b]indoles
|
|
WO2014042433A2
(en)
|
2012-09-14 |
2014-03-20 |
Kainos Medicine, Inc. |
Compounds and compositions for modulating adenosine a3 receptor activity
|
|
TW201412740A
(zh)
|
2012-09-20 |
2014-04-01 |
Bayer Pharma AG |
經取代之吡咯并嘧啶胺基苯并噻唑酮
|
|
CN104812389B
(zh)
|
2012-09-24 |
2020-07-17 |
润新生物公司 |
某些化学实体、组合物及方法
|
|
JP6465803B2
(ja)
|
2012-10-22 |
2019-02-06 |
シティ・オブ・ホープＣｉｔｙ ｏｆ Ｈｏｐｅ |
Ｅｔｐ誘導体
|
|
ES2628529T3
(es)
|
2012-10-24 |
2017-08-03 |
|
Tintes de cianina-azaindolina sustituidos con hidroxamato, y bioconjugados de los mismos
|
|
BR112015012454B1
(pt)
|
2012-12-07 |
2022-07-05 |
Vertex Pharmaceuticals Incorporated |
Compostos inibidores de atr quinase, seu uso e composição farmacêutica compreendendo os mesmos
|
|
WO2014143242A1
(en)
|
2013-03-15 |
2014-09-18 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
|
WO2014143241A1
(en)
|
2013-03-15 |
2014-09-18 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
|
US20150158868A1
(en)
|
2013-12-06 |
2015-06-11 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
|
ES2768678T3
(es)
|
2013-12-06 |
2020-06-23 |
Vertex Pharma |
Compuesto de 2-amino-6-fluoro-N-[5-fluoro-piridin-3-il]pirazolo[1,5-a]pirimidin-3-carboxamida útil como inhibidor de la ATR quinasa, su preparación, diferentes formas sólidas y derivados radiomarcados de las mismas
|
|
ES2777608T3
(es)
|
2014-06-05 |
2020-08-05 |
Vertex Pharma |
Derivados radiomarcados de un compuesto de 2-amino-6-fluoro-N-[5-fluoro-piridin-3-il]-pirazolo[1,5-a]pirimidin-3-carboxamida útiles como inhibidores de ATR cinasa, la preparación de dicho compuesto y diferentes formas sólidas del mismo
|
|
KR20170016498A
(ko)
|
2014-06-17 |
2017-02-13 |
버텍스 파마슈티칼스 인코포레이티드 |
Chk1 및 atr 저해제의 병용물을 사용하는 암의 치료 방법
|